GOOGL - Alphabet Inc.

Insider Sale by Arnold Frances (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Arnold Frances, serving as Dir at Alphabet Inc. (GOOGL), sold 112 shares at $302.99 per share, for a total transaction value of $33,935.00. Following this transaction, Arnold Frances now holds 22,464 shares of GOOGL.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Alphabet Inc. operates in the COMMUNICATION SERVICES sector, specifically within the INTERNET CONTENT & INFORMATION industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Arnold Frances

Arnold Frances

Dir

Frances H. Arnold (born July 25, 1956) is an American chemical engineer, Nobel Laureate, and independent director on the board of Alphabet Inc. (GOOGL) since 2019, where she serves on the Nominating and Corporate Governance Committee.[[1]](https://fintool.com/app/research/companies/GOOGL/people/frances-arnold)[[2]](https://en.wikipedia.org/wiki/Frances_Arnold) As the Linus Pauling Professor of Chemical Engineering, Bioengineering, and Biochemistry at the California Institute of Technology (Caltech), she directs the Donna and Benjamin M. Rosen Bioengineering Center and leads research in protein engineering via directed evolution.[[1]](https://fintool.com/app/research/companies/GOOGL/people/frances-arnold)[[2]](https://en.wikipedia.org/wiki/Frances_Arnold)[[8]](https://cce.caltech.edu/people/frances-h-arnold) Arnold earned her Ph.D. and completed postdoctoral work at Berkeley before joining Caltech in 1986, advancing through professorial ranks.[[2]](https://en.wikipedia.org/wiki/Frances_Arnold) She received the 2018 Nobel Prize in Chemistry for pioneering directed evolution of enzymes and is a member of the U.S. National Academies of Science, Medicine, and Engineering, and the American Academy of Arts and Sciences.[[1]](https://fintool.com/app/research/companies/GOOGL/people/frances-arnold)[[2]](https://en.wikipedia.org/wiki/Frances_Arnold) Career highlights include co-founding biotech firms Gevo (2005, renewable fuels), Provivi (2013, pest control), and Aralez Bio (unnatural amino acids), holding over 40 U.S. patents, and board roles at Illumina since 2016; she also co-chaired President Biden's PCAST.[[1]](https://fintool.com/app/research/companies/GOOGL/people/frances-arnold)[[2]](https://en.wikipedia.org/wiki/Frances_Arnold)[[3]](https://kids.kiddle.co/Frances_Arnold)[[5]](https://cen.acs.org/biological-chemistry/synthetic-biology/Frances-Arnold-on-founding-a-company-Building-the-right-teams-is-critical/98/i9)[[6]](https://yale2025.yale.edu/honorary-degrees/frances-h-arnold)

View full insider profile →

Trade Price

$302.99

Quantity

112

Total Value

$33,935.00

Shares Owned

22,464

Trade Date

Monday, March 2, 2026

3 days ago

SEC Filing Date

Wednesday, March 4, 2026

Filed 2 days after trade

COMMUNICATION SERVICESINTERNET CONTENT & INFORMATION

About Alphabet Inc.

Company Overview

No company information available
View news mentioning GOOGL

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4498160

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime